Research workbench
AlphaFold monomer V2.0 prediction for neuromacin (A8V0B3)
Analyse AlphaFold monomer V2.0 prediction for neuromacin (A8V0B3) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- Accession
- A8V0B3
- Type
- protein
- Length
- 82 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x9a16e2ba530Eb8eb0711578707D5d2408e91C7E5
- Molecule
- Neuromacin
- UniProt
- A8V0B3
- Pockets
- 1 · best druggability 0.33
Structure
1 distinct chain · 41% helix, 15% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Neuromacin | protein | 82 | 41% helix, 15% strand | A8V0B3 |
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 55 | 0.33 | 0.77 | 13 | empty |
Modifications
Observed in the structure: 4 disulfide (disulfide).
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A8V0B3
- Elsewhere: UniProt A8V0B3 · AlphaFold DB A8V0B3
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.